White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies

Documenti analoghi

• Investigating the relationship between sleep disturbances and white matter hyperintensities in older adults on the Alzheimer's disease spectrum
  di: Farooq Kamal, et al.
  Pubblicazione: (2024)
• Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy
  di: Kazuki Yamada, et al.
  Pubblicazione: (2026)
• Patients’ choices and eligibility for anti‐amyloid therapy in Japan's universal insurance
  di: Ryoko Ihara, et al.
  Pubblicazione: (2026)
• Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
  di: Soheil Mohammadi, et al.
  Pubblicazione: (2025)
• Toward alpha‐synuclein seed amplification assay in clinical practice
  di: Mathieu Verdurand, et al.
  Pubblicazione: (2025)